StockWatch
·

SMS Lifesciences India Ltd Q3 FY25 Results

HALEOSLABSQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue84.607.8%
Total Income84.665.2%
Expenditure77.742.6%
PBT6.9247.0%
Net Profit4.8547.1%
OPM1.14%5.26pp
NPM5.73%1.63pp
EPS18.0816.9%
View full financials

Informational and educational content only. Not investment advice.